期刊文献+

宫颈癌前哨淋巴结检测的初步探讨 被引量:16

Sentinel Lymph Node Identification with Methylene Blue in Cervical Cancer
在线阅读 下载PDF
导出
摘要 背景与目的:近几年已开展宫颈癌前哨淋巴结(sentinellymphnode,SLN)的研究,目前影响宫颈癌SLN的检出还存在很多未知因素。本研究使用亚甲蓝作为示踪剂检测宫颈癌SLN,分析影响SLN检出的因素。方法:41例宫颈癌Ⅰb1~Ⅱb期患者,术前90~400min在宫颈瘤周分4~6点注射亚甲蓝2~4ml,蓝染淋巴结即定为SLN,术后将SLN行多层切片HE染色和细胞角蛋白(cytokeratin,CK)免疫组化,其余淋巴结作常规病理检查,根据SLN检出率、假阴性率来探讨使用亚甲蓝检测宫颈癌SLN的影响因素。结果:41例中,31例成功定位出SLN共85枚,总检出率为75.6%,最常见部位为闭孔窝淋巴结。其中未行术前放化疗者检出率为87.0%(20/23);已行术前放化疗者检出率为61.1%(11/18)。27例注射亚甲蓝量为2~3ml的患者检出率仅为63.0%(17/27),显著低于注射量为3.4~4ml的患者(100%,14/14)。病理结果示:一共8例患者有盆腔淋巴结转移。结论:使用亚甲蓝检测宫颈癌SNL的注射剂量以3~4ml为宜。宫颈癌SLN定位个体差异较大,以闭孔窝最多见。 BACKGROUND &OBJECTIVE: Study of sentinel lymph node(SLN) in cerv ic al cancer has been initiated since recent years, and there are still a lot of un known factors about SLN identification in cervical cancer. This study was to inv estigate influential factors of identifying SLN with methylene blue in cervical cancer. METHODS: For 41 patients with cervical cancer enrolled from Jun. 2002 to May 2003, 2-4 ml of methylene blue was injected into cervix at 4-6 sites arou nd the tumor about 90-400 min before operation. The blue-dyed lymph node (BDLN ) was considered as SLN. HE staining in step sections, and immunohistochemistry were applied to detect SLN. The influential factors of using methylene blue to d etect SLN in cervical cancer were assessed based on the identification rate of S LN, and its false negative rate. RESULTS: SLNs were detected in 31 of 41(75.6%) patients with cervical cancer of stage Ⅰb1-Ⅱb. A total of 85 SLNs were ident ified,and most frequently located in obturator fossa. SLNs were successfully det ected in 20 of 23 (87.0%) patients who had no preoperative radiotherapy or chem otherapy, while in only 11 of 18 (61.1%) patients who had preoperative radiothe rapy and/or chemotherapy. SLNs were detected in only 17 of 27(63.0%) patients w ho were injected with 2-3 ml of methylene blue, while in all of 14 patients who se dose was 3.4-4 ml. Eight patients were confirmed of lymph node metastases by pathology. CONCLUSIONS: The dose of methylene blue recommended to detect SLN in cervical cancer is 3-4 ml. SLN varies in different sites, but most frequently located in obturator fossa.
出处 《癌症》 SCIE CAS CSCD 北大核心 2004年第9期1089-1092,共4页 Chinese Journal of Cancer
关键词 宫颈肿瘤 前哨淋巴结 亚甲蓝 多层切片 免疫组化 Cervix neoplasm Sentinel lymph node Methylene blue Step section Immunohistochemistry
  • 相关文献

参考文献13

  • 1Malur S, Krause N, Kohler C, et al. Sentinel lymph node detection in patients with cervical cancer [J]. Gynecol Oncol, 2001, 80(2): 254- 257.
  • 2袁颂华.前哨淋巴结在妇科恶性肿瘤中的研究进展[J].国外医学(肿瘤学分册),2003,30(3):233-235. 被引量:5
  • 3Barranger E, Grahek D, Cortez A, et al. Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma [J]. Cancer, 2003, 97(12):3003- 3009.
  • 4Buist MR, Pijpers RJ, Lingen A, et al. Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer [J]. Gynecol Oncol, 2003, 90(2): 290- 296.
  • 5李斌,章文华,刘琳,吴令英.前哨淋巴结检测对预测早期子宫颈癌淋巴转移的价值[J].中华妇产科杂志,2004,39(1):4-6. 被引量:26
  • 6王华英,孙建民,汤洁.子宫颈癌根治术中的淋巴显影和前哨淋巴结识别[J].中华妇产科杂志,2004,39(1):7-9. 被引量:29
  • 7盛修贵,李大鹏,刘乃富,李庆水,汤玲,李慧芹,路春华.早期子宫颈癌前哨淋巴结检测的临床意义[J].中华妇产科杂志,2004,39(1):10-13. 被引量:30
  • 8Dargent D, Martin X, Mathevet P, et al. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer [J]. Gynecol Oncol, 2000, 79(3): 411- 415.
  • 9张惜阴 王大琬 曹泽毅.子宫颈鳞状细胞浸润癌 [M]..妇科肿瘤学[C].北京:北京出版社,1998.634-669.
  • 10Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages Ⅰ B, Ⅱ A, and Ⅱ B cervical carcinoma treated with radical hysterectomy [J]. Cancer, 1999, 85(7):1547- 1554.

二级参考文献30

  • 1Paganelli G, De Cicco C, Chinol M. Sentinel node localization by lymphoscintigraphy: a reliable technique with widespread applications[ J ].Recent Results Cancer Res,2000,157:121-129.
  • 2De Cicco C, Sideri M, Bartolomei M, et al. Sentinel node biopsy in early vulvar cancer[J]. Br J Cancer,2000,82(2) :295-299.
  • 3Terada KY, Shimizu DM, Wong JH. Sentind node dissection and ultrastaging in squamous cell cancer of the vulva[J]. Gynecol Oncol,2000,76 ( 1 ) : 40-44.
  • 4Rodier JF, Janser JC, David E, et al. Radiopharmaceutical-guided surgeryin primary malignant melanoma of the vagina[J]. Gynecol Oncol, 1999,75 ( 2 ) : 308-309.
  • 5Malur S, Krause N, Kohler C, et al. Sentinel lymph node detection in patients with cervical cancer [ J ]. Gynecol Oncol, 2001,80 ( 2 ) :254-257.
  • 6Medl M, Peters Engl C, Schutz P, et al. First report of lymphatic mapping with isosulfan blue dye and sentind node biopsy in cervical cancer[J]. Anticancer Res,2000,20(2B) : 1133-1134.
  • 7Dargent D, Martin X, Mathevet P, et al. Laparoscopic assessment of the sentind lymph node in early stage cervical cancer[J]. Gynecol Oncol, 2000,79(3) :411-415.
  • 8Levenbaek C, Coleman RL, Burke TW, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphacenectomy[J ]. J Clin Oncol,2002, 20(3) :688-693.
  • 9Lantzsch T, Wolters M, Grimm J, et al. Sentinel node procedure in Ib cervical cancer: a preliminary series[J]. Br J Cancer, 2001,85(6) :791-794.
  • 10O' Boyle JD, Coleman RL, Bernstein SG, et cd. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hy-terectomy: A pilot study [ J ]. Gynecol Oncol, 2000,79 ( 2 ) : 238-243.

共引文献62

同被引文献187

引证文献16

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部